Search results

Found 30 matches for

Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.

Prieto-Alhambra Group | Pharmaco- and Device epidemiology

Find out more about

Our Groups, Centres and Units

Our Research Themes

Our Clinical Trials

Our Programme Grants

Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship

21 June 2021

Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.

Study finds marked differences in the use of ankle replacements across six countries

18 June 2021

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

17 June 2021

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

14 June 2021

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

14 June 2021

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

11 June 2021

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.